Filing Details
- Accession Number:
- 0001933414-25-000081
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-30 20:12:01
- Reporting Period:
- 2025-07-28
- Filing Date:
- 2025-07-30
- Accepted Time:
- 2025-07-30 20:12:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1933414 | Mineralys Therapeutics Inc. | MLYS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1693134 | Scott Adam Levy | 150 N. Radnor Chester Road, Suite F200 Radnor PA 19087 | Cfo And Secretary | No | Yes | No | No |
Transaction Summary
| Sold: | 73,678 shares | Avg. Price: $14.62 | Total Value: $1,077,476.77 |
| Number of Shares After Transactions: | 132,934 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-07-28 | 12,946 | $14.04 | 193,666 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-29 | 807 | $14.00 | 192,859 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-30 | 51,500 | $14.70 | 141,359 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-30 | 8,425 | $15.10 | 132,934 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.20. The Reporting Person undertakes to provideto the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within theranges set forth in this footnote (1) to this Form 4.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.01. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.06 to $15.06. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.063 to $15.130. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
Billionaire Hedge Funds
